Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Mechanism of Cardiac Arrhythmias
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 15, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Jillian Hall1, Daniel Edmundowicz1, Edmond Cronin1
1Section of Cardiology, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States of America.
Flecainide toxicity can cause advanced interatrial block, a serious heart conduction abnormality. This case highlights the critical need to monitor cardiac function during flecainide treatment.
Area of Science:
Background: